Severe dyspnea and blood-streaked, frothy sputum (Clinical manifestations of pulmonary edema include anxiety, pallor, cyanosis, clammy and cold skin, severe dyspnea, use of accessory muscles of respiration, a respiratory rate greater than 30 breaths/min, orthopnea, wheezing, and coughing with the production of frothy, blood-tinged sputum. Auscultation of the lungs may reveal crackles, wheezes, and rhonchi throughout the lungs. The heart rate is rapid, and blood pressure may be elevated or decreased.) old age, hypertension, ischemic stroke, TIA, thromboembolic events, coronary heart disease, diabetes mellitus, heart failure, obesity, hyperthyroidism, chronic kidney disease, excess alcohol use, mitral valve disease · ___________________ is characterized by a disorganized, very rapid (atrial impulses at a rate of 350 to 600 times/min), and irregular atrial rhythm, resulting in an irregular ventricular
rhythm (ventricular response is 120-200 beats per minute) New Onset Atrial Fibrillation Causes: Other
Etiologies of Atrial Fibrillation Management of Acute Atrial Fibrillation (less than 48 hours) Anticoagulants Anticoagulants Older Adults and Atrial Fibrillation Etiology of _________________________ Physical Assessment of _________________________ · Electrocardiogram (ECG) provides a graphic representation of cardiac electrical activity that provides information about cardiac dysrhythmias, myocardial ischemia, the site and extent of MI, cardiac hypertrophy, electrolyte imbalances, and the
effectiveness of cardiac drugs. · Electrocardiogram (ECG) provides a graphic
representation of cardiac electrical activity that provides information about cardiac dysrhythmias, myocardial ischemia, the site and extent of MI, cardiac hypertrophy, electrolyte imbalances, and the effectiveness of cardiac drugs. Class IA Medications: slows impulse conductions in atria, ventricles, to treat SVT, atrial flutter, and atrial fibrillation Class IB Medications: decreases conduction, automaticity for short-term treatment of ventricular dysrhythmias Class IC Medications: decreases conduction velocity in atria, ventricles to treat SVT Class II Medications: decreases HR, automaticity, and contractility to treat atrial fibrillation, atrial flutter, SVT, HTN, angina,
PVCs, ventricular tachycardia Class III Medications: used for conversion of atrial fibrillation, ventricular fibrillation, ventricular tachycardia Class IV Medications: decreases HR and force of contraction to treat atrial fibrillation and flutter, SVT, HTN, and angina A nurse is reviewing the medical record of a client who is to undergo a scheduled electrical cardioversion. For which of the following findings should the nurse report to the
provider? |